Pilot Study of Auto-immune Abnormalities Associated With Down Syndrome
NCT ID: NCT01041469
Last Updated: 2012-03-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
72 participants
OBSERVATIONAL
2009-11-30
2010-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study on Lymphocyte Subsets of Peripheral Blood in Patients With Nonmyopathic Dermatomyositis Complicated With Pulmonary Interstitial Disease
NCT06149039
Interstitial Pneumonia With Autoimmune Features: Evaluation of Connective Tissue Disease Incidence During Follow-up
NCT04179058
Collection of Blood, Bone Marrow, Leukapheresis, and Tissue Biopsy Samples From Patients and Their Family Members for Center for Human Immunology, Autoimmunity, and Inflammatory Diseases Laboratory Research Studies
NCT01200823
Comparison of CT Scan Between Patients With Axial Spondyloarthritis and Control Subjects
NCT05779969
Assessment of the Increased Risk of Infection Following an Ultratrail
NCT06089174
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
with abnormalities
Down syndrome patients presenting with at least one sign of auto immune abnormality
No interventions assigned to this group
without abnormality
Down syndrome patients without any sign of recognized auto immune condition
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* aged between 8 and 36 years
* biological or clinical signs of auto-immune disorder (group 1)
* no sign of auto-immune disorder (group 2)
Exclusion Criteria
* Current infectious disease
* Corticosteroid therapy in the last 3 weeks
* pregnancy
8 Years
36 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fondation Jérôme Lejeune
OTHER
Institut Jerome Lejeune
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Institut Jerome Lejeune
Paris, , France
Laboratoire d'Immunologie Biologique (Unité INSERM U580)
Paris, , France
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Friedman DL, Kastner T, Pond WS, O'Brien DR. Thyroid dysfunction in individuals with Down syndrome. Arch Intern Med. 1989 Sep;149(9):1990-3.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IJL-IMM-EP10
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.